Moreover, miR-125a inhibits Hyaluronan Synthase 1 [45], and clinical reports have shown that levels of hyaluronic acid reduced in patients with OSA, which is associated with inflammation and endothelial dysfunction in these patients [46]. This evidence concerns the gene HAS1 and endothelial dysfunction.